Co-Infection of SARS-CoV-2 and Klebsiella pneumoniae: A Systematic Review and Meta-Analysis

被引:1
|
作者
das Chagas, Angelica de Lima [1 ]
Araujo, Joilma Cruz da Silva [2 ]
Serra, Jaqueline Correia Pontes [1 ]
de Araujo, Kelliane Martins [1 ]
Cunha, Marcos de Oliveira [1 ]
Correia, Amanda dos Reis [1 ]
Goncalves, Laura Maria Barbosa [3 ]
Carneiro, Lilian Carla [1 ]
机构
[1] Univ Fed Goias, Hlth Sci Post Grad, BR-74605050 Goiania, GO, Brazil
[2] Univ Fed Goias, Pharm Fac, BR-74605170 Goiania, GO, Brazil
[3] Univ Fed Goias, Postgrad Program Biol Host Parasite Relationship, Goiania, GO, Brazil
关键词
bacterium; epidemiology; virology; COVID-19; PATIENTS; ANTIBIOTICS; RESISTANCE; INFECTION;
D O I
10.3390/diagnostics14111149
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The study aimed to assess the prevalence of COVID-19 and Klebsiella spp. coinfection across continents. Conducted following PRISMA guidelines, a systematic review utilized PubMed, Embase, SCOPUS, ScienceDirect, and Web of Science databases, searching for literature in English published from December 2019 to December 2022, using specific Health Sciences descriptors. A total of 408 records were identified, but only 50 were eligible, and of these, only 33 were included. Thirty-three references were analyzed to evaluate the correlation between COVID-19 and Klebsiella spp. infections. The tabulated data represented a sample group of 8741 coinfected patients. The findings revealed notable disparities in co-infection rates across continents. In Asia, 23% of individuals were infected with Klebsiella pneumoniae, while in Europe, the proportion of co-infected patients stood at 15%. Strikingly, on the African continent, 43% were found to be infected with Klebsiella pneumoniae, highlighting significant regional variations. Overall, the proportion of Klebsiella pneumoniae co-infections among COVID-positive individuals were determined to be 19%. Particularly concerning was the observation that 1 in 6 ICU coinfections was attributed to Klebsiella pneumoniae, indicating its substantial impact on patient outcomes and healthcare burden. The study underscores the alarming prevalence of co-infection between COVID-19 and Klebsiella pneumoniae, potentially exacerbating the clinical severity of patients and posing challenges to treatment strategies. These findings emphasize the importance of vigilant surveillance and targeted interventions to mitigate the adverse effects of bacterial coinfections in the context of the COVID-19 pandemic.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Co-infection of SARS-CoV-2 and influenza viruses: A systematic review and meta-analysis
    Thi Loi Dao
    Van Thuan Hoang
    Colson, Philippe
    Million, Matthieu
    Gautret, Philippe
    JOURNAL OF CLINICAL VIROLOGY PLUS, 2021, 1 (03):
  • [2] Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: A systematic review and meta-analysis
    Musuuza, Jackson S.
    Watson, Lauren
    Parmasad, Vishala
    Putman-Buehler, Nathan
    Christensen, Leslie
    Safdar, Nasia
    PLOS ONE, 2021, 16 (05):
  • [3] SARS-CoV-2 and Chlamydia pneumoniae co-infection: A review of the literature
    Celia Frutos, Maria
    Origlia, Javier
    Gallo Vaulet, Maria Lucia
    Elena Venuta, Maria
    Gabriela Garcia, Miriam
    Armitano, Rita
    Cipolla, Lucia
    Julia Madariaga, Maria
    Cuffini, Cecilia
    Estela Cadario, Maria
    REVISTA ARGENTINA DE MICROBIOLOGIA, 2022, 54 (03): : 247 - 257
  • [4] SARS-CoV-2 and HIV co-infection; clinical features, diagnosis, and treatment strategies: A systematic review and meta-analysis
    Dadashi, Masoud
    Dadashi, Ali
    Sameni, Fatemeh
    Sayadi, Shahram
    Goudarzi, Mehdi
    Nasiri, Mohammad Javad
    Yaslianifard, Somayeh
    Ghazi, Mona
    Arjmand, Reza
    Hajikhani, Bahareh
    GENE REPORTS, 2022, 27
  • [5] Asymptomatic SARS-CoV-2 infection: A systematic review and meta-analysis
    Sah, Pratha
    Fitzpatrick, Meagan C.
    Zimmer, Charlotte F.
    Abdollahi, Elaheh
    Juden-Kelly, Lyndon
    Moghadas, Seyed M.
    Singer, Burton H.
    Galvani, Alison P.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (34)
  • [6] Co-infection of SARS-CoV-2 and influenza A/B among patients with COVID-19: a systematic review and meta-analysis
    Golpour, Monireh
    Jalali, Hossein
    Alizadeh-Navaei, Reza
    Talarposhti, Masoumeh Rezaei
    Mousavi, Tahoora
    Ghara, Ali Asghar Nadi
    BMC INFECTIOUS DISEASES, 2025, 25 (01)
  • [7] COLCHICINE TREATMENT IN SARS-COV-2 INFECTION: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Beran, Azizullah Beran
    Mhanna, Mohammed
    Waseem, Wahood
    Ghazaleh, Sami
    Sajdeya, Omar
    Kalifa, Muhamad
    Ayesh, Hazem
    Srour, Omar
    Mhanna, Asmaa
    Altorok, Nezam
    Assaly, Ragheb
    CHEST, 2021, 160 (04) : 521A - 521A
  • [8] Colchicine Treatment in SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis
    Beran, Azizullah
    Mhanna, Mohammed
    Wahood, Waseem
    Ghazaleh, Sami
    Sajdeya, Omar
    Kalifa, Muhamad
    Ayesh, Hazem
    Srour, Omar
    Mhanna, Asmaa S.
    Altorok, Nezam
    Assaly, Ragheb
    AMERICAN JOURNAL OF THERAPEUTICS, 2022, 29 (01) : E95 - E98
  • [9] Andrological effects of SARS-Cov-2 infection: a systematic review and meta-analysis
    G. Corona
    W. Vena
    A. Pizzocaro
    F. Pallotti
    D. Paoli
    G. Rastrelli
    E. Baldi
    N. Cilloni
    M. Gacci
    F. Semeraro
    A. Salonia
    S. Minhas
    R. Pivonello
    A. Sforza
    L. Vignozzi
    A. M. Isidori
    A. Lenzi
    M. Maggi
    F. Lombardo
    Journal of Endocrinological Investigation, 2022, 45 : 2207 - 2219
  • [10] Andrological effects of SARS-Cov-2 infection: a systematic review and meta-analysis
    Corona, G.
    Vena, W.
    Pizzocaro, A.
    Pallotti, F.
    Paoli, D.
    Rastrelli, G.
    Baldi, E.
    Cilloni, N.
    Gacci, M.
    Semeraro, F.
    Salonia, A.
    Minhas, S.
    Pivonello, R.
    Sforza, A.
    Vignozzi, L.
    Isidori, A. M.
    Lenzi, A.
    Maggi, M.
    Lombardo, F.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2022, 45 (12) : 2207 - 2219